Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

XROCK issues voluntary recall of certain supplement products

PBR Staff Writer Published 24 April 2012

XROCK Industries has issued a voluntary recall of certain supplement products sold by the company under the brand name of X-ROCK, due to the presence of potentially hazardous ingredient.

The FDA conducted analytical tests of X-ROCK for men, which showed that products contained sildenafil and hydroxythiohomosildenafil.

Hydroxythiohomosildenafil is an analogue sildenafil and is expected to possess a similar pharmacological and adverse event profile.

The sildenafil and hydroxythiohomosildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and lower blood pressure to dangerous levels.

Additionally, hydroxythiohomosildenafil, like sildenafil, may cause side effects, such as headaches and flushing.

Comments
Post a comment

Comments may be moderated for spam, obscenities or defamation.